SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-18-002895
Filing Date
2018-07-13
Accepted
2018-07-13 06:09:11
Documents
80
Period of Report
2018-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm 10-Q 495361
2 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 14298
3 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 5746
  Complete submission text file 0001062993-18-002895.txt   4197011

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE lxrp-20180531.xml EX-101.INS 599524
5 XBRL SCHEMA FILE lxrp-20180531.xsd EX-101.SCH 93590
6 XBRL CALCULATION FILE lxrp-20180531_cal.xml EX-101.CAL 48501
7 XBRL DEFINITION FILE lxrp-20180531_def.xml EX-101.DEF 406922
8 XBRL LABEL FILE lxrp-20180531_lab.xml EX-101.LAB 576252
9 XBRL PRESENTATION FILE lxrp-20180531_pre.xml EX-101.PRE 456658
Mailing Address 156 VALLEYVIEW ROAD KELOWNA A1 V1X 3M4
Business Address 156 VALLEYVIEW ROAD KELOWNA A1 V1X 3M4 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52138 | Film No.: 18951537
SIC: 1000 Metal Mining
Assistant Director 9